Rational Combinations 360° Summit Confirms Program Line-Up for September 13-14, 2018

Share Article

The 3rd annual Rational Combinations 360°, organized by the Conference Forum, presents a two day agenda providing the most up-to-date research, data and progress to help IO stakeholders fight a wider range of cancers.

Rational Combinations 360°

“We are pleased to continue to deliver the leading industry event specializing in important updates for the community on current research in immunotherapy combinations,” said Kate Woda, Conference Director.

The Conference Forum announced the agenda and speaking faculty for the 3rd Annual Rational Combinations 360° event, scheduled for September 13-14, 2018 at the Wyndham Philadelphia. The speaking faculty is committed to covering a 360° comprehensive view on business aspects, clinical advancements and scientific data for immuno-oncology combination strategies to help IO stakeholders fight a wider range of cancers.

Keynoting is Dr Steven Rosenberg, Chief of Surgery Branch, the National Cancer Institute who will discuss cancer immunotherapy using the adoptive cell transfer of autologous lymphocytes with antitumor activity with an emphasis on the identification of T-cells that recognize the products of mutations unique to the individual patient’s cancer.

Rational Combinations 360° will also feature Dr Jason Luke, the University of Chicago, who will provide a full analysis and lessons learned on the recent IDO plus Keytruda combination trial.

Lead Advisors Dr Patrick Hwu, MD Anderson Cancer Center, Dr Axel Hoos, GSK and Dr Ian McCaffery, Janssen chair the third annual Rational Combinations 360° event. They will be joined by a number of distinguished speakers including, but not limited to, Dr Roy Baynes of Merck, Dr Daniel Chen of Genentech, Dr Amanda Bruno of GSK, Dr Philip Gotwals of Novartis Institutes for Biomedical Research, Dr Michael Kalos of Janssen Oncology, Dr Maria Jure Kunkel of Medimmune, and Dr Ke Liu of the FDA.

The conference includes seven plenary sessions with data presentations and panel discussions on Discovery/Preclinical Science, Translational Science, Biomarkers and Diagnostics, Clinical Operations and Development, Business Aspects, Financial and Commercial Implications and Emerging Technologies.

“We are pleased to continue to deliver the leading industry event specializing in important updates for the community on current research in immunotherapy combinations,” said Kate Woda, Conference Director.

Rational Combinations 360° will also feature extensive networking opportunities including one-on-one partnering meetings and there will be a designated exhibit area featuring service and technology companies.

See full event details for Rational Combinations 360°.

About the Conference Forum
The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high quality networking.

About Rational Combinations 360˚
Rational Combinations 360˚ is a two-day conference focused on the combinations used in immunotherapy to treat various forms of cancer. Rational Combinations 360° was born from the Conference Forum’s Immuno-Oncology 360˚ event as the need for a more focused program on combinations became increasingly clear with the enormous increase in overall investment.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Margaret Van Cleve
The Conference Forum LLC
+1 (646) 350-2580 Ext: 415
Email >
@ConferenceForum
Follow >
The Conference Forum
Like >